Laboratory for Advanced Medicine
Our company was founded on the efforts of two leading scientific teams.
The team at the Institute of Genomic Medicine at the University of California, San Diego determined that methylation was the best method to accurately detect cancers, and later developed the technology that is used in our laboratories today.
In 2014, another team, led by Dr. Shu Li, formed Laboratory for Advanced Medicine to focus on the commercialization of methylation cancer detection testing with a US CLIA lab.
Laboratory for Advanced Medicine (LAM) incorporates the efforts of those teams. The company has CLIA and CAP certified laboratories, and cGMP facilities working towards bringing first-class technologies to the medical community.
We operate globally in the United States and China, collaborating with leading scientists, physicians, research institutions and business leaders.
The company is headquartered in the United States with offices in California, Indiana and Texas. In China, the company has offices in Beijing, Guangzhou and Bei Dai He. We perform our research in the United States, validation in China and further validation in the U.S.